US 12,082,872 B2
Systems and methods for therapeutic nasal neuromodulation
David Townley, Clare (IE); and Brian Shields, Galway (IE)
Assigned to Neurent Medical Limited, Oranmore (IE)
Appl. No. 17/312,495
Filed by Neurent Medical Limited, Oranmore (IE)
PCT Filed Dec. 6, 2019, PCT No. PCT/IB2019/001298
§ 371(c)(1), (2) Date Jun. 10, 2021,
PCT Pub. No. WO2020/121053, PCT Pub. Date Jun. 18, 2020.
Claims priority of provisional application 62/896,845, filed on Sep. 6, 2019.
Claims priority of provisional application 62/832,914, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,917, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,918, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,920, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,923, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,925, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,927, filed on Apr. 12, 2019.
Claims priority of provisional application 62/832,928, filed on Apr. 12, 2019.
Claims priority of provisional application 62/778,233, filed on Dec. 11, 2018.
Prior Publication US 2022/0125504 A1, Apr. 28, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 18/14 (2006.01); A61B 34/10 (2016.01); A61B 34/20 (2016.01); A61N 1/05 (2006.01); A61N 1/40 (2006.01); G06T 7/00 (2017.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61B 18/02 (2006.01); A61B 18/12 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); A61B 90/00 (2016.01); A61B 90/94 (2016.01)
CPC A61B 18/1485 (2013.01) [A61B 18/14 (2013.01); A61B 34/10 (2016.02); A61B 34/20 (2016.02); A61N 1/0546 (2013.01); A61N 1/403 (2013.01); G06T 7/0012 (2013.01); A61B 2017/00199 (2013.01); A61B 2017/00292 (2013.01); A61B 2017/00424 (2013.01); A61B 2017/00867 (2013.01); A61B 2018/0016 (2013.01); A61B 2018/00166 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/00303 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00434 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00654 (2013.01); A61B 2018/00815 (2013.01); A61B 2018/00821 (2013.01); A61B 2018/00875 (2013.01); A61B 2018/00922 (2013.01); A61B 2018/00946 (2013.01); A61B 18/02 (2013.01); A61B 18/1206 (2013.01); A61B 2018/1253 (2013.01); A61B 2018/126 (2013.01); A61B 2018/1407 (2013.01); A61B 2018/144 (2013.01); A61B 2018/1467 (2013.01); A61B 2018/1475 (2013.01); A61B 2018/1823 (2013.01); A61B 18/20 (2013.01); A61B 2034/102 (2016.02); A61B 2090/3735 (2016.02); A61B 2090/3762 (2016.02); A61B 2090/378 (2016.02); A61B 90/94 (2016.02); A61B 2218/007 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A device for treating a condition within a nasal cavity of a patient, the device comprising:
a shaft and a multi-segment end effector operably coupled thereto, the multi-segment end effector is configured for delivering energy to one or more target sites within the nasal cavity of the patient, the multi-segment end effector comprises a proximal segment and a separate distal segment spaced apart from the proximal segment and each of the proximal and distal segments is transformable between a retracted configuration and an expanded deployed configuration;
wherein the proximal segment comprises:
a first pair of flexible support elements each comprising one or more energy delivering elements arranged thereon, the first pair of flexible support elements extend in a first outward direction relative to a longitudinal axis along which the shaft lies and cooperatively form an inwardly extending first concave shape relative to the longitudinal axis when the first segment is in the expanded deployed configuration; and
a second pair of flexible support elements each comprising one or more energy delivering elements arranged thereon, the second pair of flexible support elements extend in a second outward direction relative to the longitudinal axis and opposing the first outward direction and cooperatively form an inwardly extending second concave shape relative to the longitudinal axis and opposing the first concave shape when the first segment is in the expanded deployed configuration.